Linda Marban - 03 Mar 2025 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Linda Marban
Issuer symbol: CAPR
Transactions as of: 03 Mar 2025
Net transactions value: +$34,750
Form type: 4
Filing time: 05 Mar 2025, 17:00:13 UTC
Previous filing: 06 Jan 2025
Next filing: 07 Jan 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CAPR	Common Stock	Options Exercise	$34,750	+25,000	+13%	$1.39	223,604	03 Mar 2025	Direct
transaction	CAPR	Common Stock	Other	$0	-12,500	-5.6%	$0.000000	211,104	05 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CAPR	Stock Option (Right to Buy)	Options Exercise	$0	-25,000	-100%	$0.000000	0	03 Mar 2025	Common Stock	25,000	$1.39	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transferred to reporting person's ex-spouse pursuant to settlement in divorce proceeding.
F2	This option was granted on March 3, 2015 and was previously covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
F3	Shares vested 1/48th on the first day of each month commencing April 1, 2015.